HRP20210103T1 - Postupak za proizvodnju spoja pirol0[3,2-d]pirimidina, kao i odgovarajućih intermedijera - Google Patents

Postupak za proizvodnju spoja pirol0[3,2-d]pirimidina, kao i odgovarajućih intermedijera Download PDF

Info

Publication number
HRP20210103T1
HRP20210103T1 HRP20210103TT HRP20210103T HRP20210103T1 HR P20210103 T1 HRP20210103 T1 HR P20210103T1 HR P20210103T T HRP20210103T T HR P20210103TT HR P20210103 T HRP20210103 T HR P20210103T HR P20210103 T1 HRP20210103 T1 HR P20210103T1
Authority
HR
Croatia
Prior art keywords
image
compound
formula
acid
sodium
Prior art date
Application number
HRP20210103TT
Other languages
English (en)
Croatian (hr)
Inventor
Zhaozhong DING
Fei Sun
Yinghu HU
Yilong ZHOU
Rui Zhao
Ling Yang
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. filed Critical Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Publication of HRP20210103T1 publication Critical patent/HRP20210103T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HRP20210103TT 2016-02-05 2017-02-04 Postupak za proizvodnju spoja pirol0[3,2-d]pirimidina, kao i odgovarajućih intermedijera HRP20210103T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610082028.3A CN107043378A (zh) 2016-02-05 2016-02-05 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
EP17747006.9A EP3412673B1 (en) 2016-02-05 2017-02-04 Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
PCT/CN2017/072893 WO2017133686A1 (zh) 2016-02-05 2017-02-04 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体

Publications (1)

Publication Number Publication Date
HRP20210103T1 true HRP20210103T1 (hr) 2021-03-05

Family

ID=59500148

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20210103TT HRP20210103T1 (hr) 2016-02-05 2017-02-04 Postupak za proizvodnju spoja pirol0[3,2-d]pirimidina, kao i odgovarajućih intermedijera

Country Status (28)

Country Link
US (2) US10654856B2 (cg-RX-API-DMAC10.html)
EP (1) EP3412673B1 (cg-RX-API-DMAC10.html)
JP (1) JP6877449B2 (cg-RX-API-DMAC10.html)
KR (1) KR102371500B1 (cg-RX-API-DMAC10.html)
CN (2) CN107043378A (cg-RX-API-DMAC10.html)
AR (1) AR107549A1 (cg-RX-API-DMAC10.html)
AU (1) AU2017214134B2 (cg-RX-API-DMAC10.html)
BR (1) BR112018015879B1 (cg-RX-API-DMAC10.html)
CA (1) CA3013520C (cg-RX-API-DMAC10.html)
CL (1) CL2018002094A1 (cg-RX-API-DMAC10.html)
DK (1) DK3412673T3 (cg-RX-API-DMAC10.html)
EA (1) EA034581B1 (cg-RX-API-DMAC10.html)
ES (1) ES2852323T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20210103T1 (cg-RX-API-DMAC10.html)
HU (1) HUE053455T2 (cg-RX-API-DMAC10.html)
IL (1) IL260999B (cg-RX-API-DMAC10.html)
LT (1) LT3412673T (cg-RX-API-DMAC10.html)
MX (1) MX374298B (cg-RX-API-DMAC10.html)
MY (1) MY190551A (cg-RX-API-DMAC10.html)
NZ (1) NZ744885A (cg-RX-API-DMAC10.html)
PH (1) PH12018501642A1 (cg-RX-API-DMAC10.html)
PL (1) PL3412673T3 (cg-RX-API-DMAC10.html)
PT (1) PT3412673T (cg-RX-API-DMAC10.html)
SG (1) SG11201806685VA (cg-RX-API-DMAC10.html)
SI (1) SI3412673T1 (cg-RX-API-DMAC10.html)
TW (1) TW201728590A (cg-RX-API-DMAC10.html)
UA (1) UA124100C2 (cg-RX-API-DMAC10.html)
WO (1) WO2017133686A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9815850B2 (en) 2016-02-05 2017-11-14 Denali Therapeutics Inc. Compounds, compositions and methods
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
BR112021015577A2 (pt) 2019-02-08 2021-10-05 Research & Business Foundation Sungkyunkwan University Complexo-colesterol agonista do receptor toll-like 7 ou 8 e uso do mesmo
CN115666637A (zh) 2020-03-02 2023-01-31 蛋白科技先锋 基于病原体细胞壁骨架的模拟活病原体的纳米粒子及其制备方法
EP4194008A4 (en) 2020-08-04 2025-01-08 Progeneer Inc. Kinetically acting adjuvant ensemble
WO2022031021A1 (ko) 2020-08-04 2022-02-10 성균관대학교산학협력단 동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신
US20230277525A1 (en) 2020-08-04 2023-09-07 Progeneer Inc Conjugate of functional drug and toll-like receptor 7 or 8 agonist of which active site is temporarily inactivated and use thereof
EP4463229A1 (en) 2022-01-12 2024-11-20 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide
WO2025110816A1 (ko) 2023-11-23 2025-05-30 프로지니어 주식회사 암의 치료를 위한 활성화 부위가 일시적으로 비활성화된 톨-유사 수용체 7 또는 8 작용자와 항암 치료의 병용요법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009082247A1 (en) 2007-12-21 2009-07-02 Industrial Research Limited Process for preparing immucillins having a methylene link
UY32306A (es) 2008-12-09 2010-07-30 Gilead Sciences Inc Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos
MX386924B (es) * 2012-10-10 2025-03-19 Janssen Sciences Ireland Uc Derivados pirrolo[3,2-d]pirimidínicos para el tratamiento de infecciones víricas y otras enfermedades.
JP6216387B2 (ja) * 2012-11-20 2017-10-18 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC 新規化合物
SMT201700378T1 (it) * 2012-11-20 2017-09-07 Glaxosmithkline Llc Nuovi composti
WO2015168269A1 (en) * 2014-05-01 2015-11-05 Novartis Ag Compounds and compositions as toll-like receptor 7 agonists
CN112898308B (zh) 2014-08-15 2026-08-07 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
CN105367576A (zh) 2014-08-15 2016-03-02 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
KR102112192B1 (ko) * 2015-11-05 2020-05-19 치아타이 티안큉 파마수티컬 그룹 주식회사 Tlr7 효능제로서의 7-(티아졸-5-일)피롤로피리미딘 화합물
CN107043377A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的三氟乙酸盐、晶型b及其制备方法、药物组合物和用途
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
CN107043379A (zh) 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的晶型a、其制备方法和医药用途

Also Published As

Publication number Publication date
EP3412673B1 (en) 2020-11-25
HK1259183A1 (zh) 2019-11-29
LT3412673T (lt) 2021-03-10
IL260999B (en) 2021-02-28
BR112018015879B1 (pt) 2024-02-15
CN108602832B (zh) 2020-10-09
HUE053455T2 (hu) 2021-06-28
US10654856B2 (en) 2020-05-19
CA3013520A1 (en) 2017-08-10
WO2017133686A1 (zh) 2017-08-10
JP6877449B2 (ja) 2021-05-26
PH12018501642B1 (en) 2019-06-03
CN107043378A (zh) 2017-08-15
KR102371500B1 (ko) 2022-03-07
AU2017214134B2 (en) 2020-08-27
PL3412673T3 (pl) 2021-07-26
UA124100C2 (uk) 2021-07-21
KR20180104724A (ko) 2018-09-21
EP3412673A4 (en) 2019-07-03
EP3412673A1 (en) 2018-12-12
BR112018015879A2 (pt) 2018-12-26
PH12018501642A1 (en) 2019-06-03
EA201891769A1 (ru) 2019-04-30
AU2017214134A1 (en) 2018-08-23
PT3412673T (pt) 2021-02-15
AR107549A1 (es) 2018-05-09
CA3013520C (en) 2022-07-19
ES2852323T3 (es) 2021-09-13
SG11201806685VA (en) 2018-09-27
US20190040072A1 (en) 2019-02-07
MY190551A (en) 2022-04-27
JP2019505531A (ja) 2019-02-28
CL2018002094A1 (es) 2018-12-07
US20200239484A1 (en) 2020-07-30
SI3412673T1 (sl) 2021-04-30
MX2018009502A (es) 2018-12-11
EA034581B1 (ru) 2020-02-21
MX374298B (es) 2025-03-06
NZ744885A (en) 2022-07-01
TW201728590A (zh) 2017-08-16
CN108602832A (zh) 2018-09-28
DK3412673T3 (da) 2021-01-18

Similar Documents

Publication Publication Date Title
HRP20211193T1 (hr) Postupak za sintezu 2-hidroksi-6-((2-(1-izopropil-1h-pirazol-5-yl)-piridin-3-yl)metoksi)benzaldehida
SI2428519T1 (sl) Sestavek za pripravo 17-vinil-triflatov kot intermediatov
MX2011009807A (es) Compuestos.
JP2019505531A5 (cg-RX-API-DMAC10.html)
JP2004523529A5 (cg-RX-API-DMAC10.html)
JP4788343B2 (ja) ニトリル化合物、カルボン酸化合物又はカルボン酸エステル化合物の製法
UA101712C2 (ru) Способ производства производных замещенной метоксиметилпиридин-2,3-дикарбоновой кислоты
NZ744885A (en) Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
Paine III A convenient synthesis of nicotinate esters from 3‐cyanopyridones
JP2016500657A5 (cg-RX-API-DMAC10.html)
PL84493B1 (cg-RX-API-DMAC10.html)
JP6332818B2 (ja) チカグレロルの中間体およびその製造法、およびチカグレロルの製造法
BRPI0721386B1 (pt) processo para preparação de 2-substituídas -5-(1-alquiltio)-alquil piridinas, e intermediário
WO2015012110A1 (ja) C-グリコシド誘導体の製造方法
IL275655B1 (en) A process for the preparation of amino-pyrimidine and its intermediates
ES2784835T3 (es) Método de preparación de silodosina y sus compuestos intermedios
EP2982673A1 (en) Process for manufacturing 5-chloromethyl-2,3-dicarboxylic anhydride
KR101251561B1 (ko) 아리피프라졸의 제조에 유용한 신규 중간체, 이의 제조방법 및 이를 이용한 아리피프라졸의 제조 방법
US4065459A (en) Process for the preparation of thieno(3,2-c) pyridine and derivatives thereof
HU195964B (en) Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients
HRP20210376T1 (hr) Novi intermedijeri za pripremu remifentanil hidroklorida
CN102206187B (zh) 6-苄基-1-乙氧甲基-5-异丙基尿嘧啶及其类似物的合成方法
HRP20170394T1 (hr) Postupak za sintezu 3,4-dimetoksibiciklo[4.2.0]okta-1,3,5-trien-7-karbonitrila i uporaba za sintezu ivabadina i njegovih adicijskih soli s farmacetuski prihvatljivom kiselinom
ES2392735T3 (es) Método para producir un derivado de ácido nicotínico o una sal del mismo
CN103553917B (zh) 3,7,11-三甲基-2,4,6,10-十二烷基四烯醇乙酸酯的制备方法及其应用